Biotech Investor Relations Firm
From drug development companies in the preliminary research stage to BLA/NDA, clinical trials, preclinical testing, IND-enabling studies, medical devices or post-market surveillance our team is able to help along every step of the way.
Our investor relations firm uses market data combined with extensive experience in the space for the development of biotech investor relations programs that create success with investors.
Futurist Society investor relations initially will work alongside your team creating a process that tells your story from founding to the future ahead. From your technology to patents, our team understands every step of the way and the intricate nature of developing companies in pre-clinical stage.
Technology is the foundation of your company, but understanding the scientific level details is not necessary for investors to understand the value your company offers and the developing potential that exists. Helping to explain what you are working on now in addition to the benefits developed for patients is key to driving the value proposition home and maximizing your investors interest.
Our work together initially begins by understanding your mission and values along with the patents and technology that exists. From there we review your pipeline and future plans so that we can begin to model a story that blends who you are, where you have been and where you are going into one key synergistic message driving the company value among other biotechs in the space. Investors have many options in their search for profits, and communicating things directly can help to offset the risk that occurs in the unknown of biotechs and drug development.
From New York, NY to San Diego, San Francisco, Boston or Atlanta we are here to support your company throughout the United States and global investment network.
A Biotech Investor Relations Firm That Understands The Industry
Futurist Society is a leading provider of Investor Relations services for small and mid-cap Biotech companies. We have a proven track record of helping our clients effectively communicate their story to the investment community and other key stakeholders.
Our team has extensive experience working with Biotech companies at all stages of development and therapeutic areas from pre-IPO to publicly traded. We understand the challenges that Biotech companies face when it comes to Investor Relations and we are dedicated to helping our clients achieve their business objectives.
Contact us today to learn more about our services.
Investor Relations Services for Biotech Companies
Your search for comprehensive and integrated investor relations (IR) services stops here. At Futurist Society, we understand that as a Biotech company, you need to focus on your core competencies – developing life-saving or life-enhancing therapies and products. You cannot afford to be bogged down with the day-to-day management of your IR program. This is where we come in.
As a full-service IR firm, we offer a complete suite of services that will enable you to effectively communicate your story to the investment community and other key stakeholders. We will work with you to develop and execute a customized IR plan that is aligned with your business objectives.
Futurist Society Biotech IR Offerings
Below is just a sample of the services available to Futurist Society clients all working in tandem to increase your stock visibility.
| • Investor Targeting and Outreach |
| • Corporate Communications |
| • Financial Communication |
| • Crisis Communication |
| • Shareholder Engagement Communication Programs |
| • Equity Research Coverage |
| • Institutional Investor Relations |
| • Financial Reporting |
| • Investor Relations Consulting |
| • Retail Investor Relations |
| • Media Relations |
| • Investor Conferences and Roadshows |
| • Shareholder Communication Programs |
| • Social Media and Digital Investor Relations |
| • Investor Days |
| • Analyst Coverage |
| • New Product Launches |
| • FDA Approvals |
| • Investor Relations Website Design and Development |
Investor Targeting and Outreach
Raising the visibility to investors is a top priority for any public company. Targeting the right investors with your message helps ensure that you are reaching those who are most likely to invest. Our team has decades of experience targeting and reaching investors through a variety of channels including public relations, major social media networks like reddit, StockTwits and Twitter, broker dealers, investment banks, newsletters, conferences, and other means.
Corporate Communications
Your company’s story is much more than just the numbers. It is the sum of all of the parts that make up your company – your history, culture, people, products, and more. We will work with you to develop a corporate narrative that investors can connect with and understand. This narrative will be the foundation of all of your communications with the investment community.
Financial Communication
Your financial story is complex. We will work with you to develop clear and concise messages that articulate your value proposition to the investment community. This includes preparing earnings releases, building presentations for earnings calls and roadshows, writing healthcare research reports and articles for publication in leading investment publications.
Crisis Communication
The biotech industry is highly regulated with a lot of moving parts. As such, companies in this space are susceptible to crises that can have a material impact on the stock price. We have extensive experience dealing with biotech-related crises including FDA investigations, clinical trial failures, regulatory affairs, and product recalls. We will work with you to develop a crisis communication plan and provide on-going support to help you navigate through these challenges.
Shareholder Engagement Communication Programs
It is important to keep your shareholders informed and engaged. We can help you develop biotech investor relations programs and execute a shareholder engagement program that includes regular communication with shareholders, proxy campaigns, and investor days.
Equity Research Coverage
The biotech sector is one of the most dynamic and innovative industries in the world. Equity research coverage from analysts is critical for companies in this space to attract and retain investors. We have a proven track record of securing and maintaining equity research coverage from sell side analysts at leading investment banks and research firms.
Institutional Investor Relations
Building and maintaining relationships with the institutional investor community is a key focus for public biotech companies on Wall Street. We will work with you to develop and execute an IR program that targets the right institutions with your message. This includes regular communication with investors, roadshows, non-deal roadshows, and participation in conferences.
Financial Reporting
We will work with you to ensure that you are in compliance with all financial reporting requirements. This includes preparing and filing periodic reports with the Securities and Exchange Commission (SEC), such as 10-Qs and 10-Ks.
Investor Relations Consulting
Our team has decades of experience working with public companies, both large and small. We offer a wide range of IR consulting services that are designed to help companies achieve their business objectives.
We will work with you to ensure that you are in compliance with all financial reporting requirements. This includes preparing and filing periodic reports with the Securities and Exchange Commission (SEC), such as 10-Qs and 10-Ks.
Retail Investor Relations
Reaching and communicating with the retail investor community is a key focus for many public companies. We will work with you to develop and execute a retail IR program that targets the right investors with your message. This includes regular communication with shareholders, social media outreach, broker dealer days, and participation in conferences.
Media Relations
The biotech industry is complex and constantly evolving. Securing media coverage can be a challenge. We have extensive experience working with the media and will work with you to develop and execute a media relations strategy that gets your story told in relevant media ranging from niche publications to major media outlets.
Investor Conferences and Roadshows
One of the best ways to reach potential investors is to participate in conferences and roadshows. We will work with you to identify the right conferences and roadshows to participate in and help you secure speaking slots. We will also help you develop and execute a roadshow schedule that targets the right investors and secures meetings that make an impact.
Shareholder Communication Programs
It is important to keep your shareholders informed and engaged. We can help you develop and execute a shareholder communication program that includes regular communication with shareholders, proxy campaigns, and investor days.
Social Media and Digital Investor Relations
Social media and digital investor relations are important tools for reaching investors. We will work with you to develop and execute a social media and digital IR strategy that gets your story told in the right channels. This includes developing content, securing speaking slots at conferences, and executing targeted social media campaigns.
Platforms like Reddit, StockTwits and Twitter have rapidly fueled the rise of many companies in recent years highlighting the potential and magnitude of the social media networks as big business outlets and assets with viable credibility.
Investor Days
An investor day is a great way to give your shareholders an update on the company’s performance and strategy. We will work with you to develop and execute an investor day that meets your goals and objectives.
This includes developing the agenda, arranging logistics, and inviting and registering guests.
Analyst Coverage
The biotech sector is one of the most dynamic and innovative industries in the world. Equity research coverage is critical for companies in this space to attract and retain investors. We have a proven track record of securing and maintaining equity research coverage from leading investment banks and research firms.
New Product Launches
Launching a new product is an exciting time for any company. We will work with you to develop and execute a launch plan that includes media relations, analyst relations, and investor relations for your new life science product. Our launches are focused on positioning through marketing with strategic programs that manage the overall awareness and visibility along with capturing feedback and market data to utilize as resources for learning and adjustments as needed to campaigns and product positioning.
FDA Approvals
The FDA approval process is complex and can be difficult to navigate. We have extensive experience working with companies that are seeking FDA approval for their products. We will work with you to develop a strategy for interacting with the FDA, preparing for FDA inspections, and managing the FDA approval process.
Investor Relations Website Design and Development
Your company’s website is often the first point of contact for investors and other key stakeholders. It is important that your website effectively communicates your story and provides easy access to key information such as financials, presentations, SEC filings, press releases, and more. We will work with you to develop and maintain an IR website that meets the needs of your audience.
Using Market Data For Real Results
At Futurist Society, we are proud to offer a complete suite of IR services with expertise that is tailored to the needs of publicly listed and private companies in the biotech space. We have a team of experienced professionals who are ready to partner with you to develop and execute an IR plan that will help you achieve your business objectives.
Life sciences companies rely on deep industry knowledge for their research and development. You should rely on the same deep industry knowledge for your investor relations needs. We use key constituencies to achieve our clients’ organizational and communications objective maximizing their position as a positive investment vehicle among the investment banking and financial community.
Don’t let your IR program be an afterthought. Contact Biotech IR today and let us help you tell your story to the investment community.
